Study of Immediate Start of Progestin Contraceptives in Medical Abortion

Overview

This study will compare immediate to post-abortion start of two progestin-based contraceptives (DMPA and etonorgestrel implants) among women having first trimester medical abortion who wish to use that method for post-abortion contraception.

Full Title of Study: “Immediate Initiation of Progestin Contraceptives in First Trimester Medical Abortion: A Randomized Controlled Trial”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Prevention
    • Masking: None (Open Label)
  • Study Primary Completion Date: December 2015

Interventions

  • Other: Timing of Contraceptive Initiation in Medical Abortion

Arms, Groups and Cohorts

  • Active Comparator: Quickstart
    • Immediate start
  • Active Comparator: Afterstart
    • Delayed start

Clinical Trial Outcome Measures

Primary Measures

  • Medical Abortion Failure
    • Time Frame: One month after enrollment
  • Repeat Pregnancy
    • Time Frame: 6 months after enrollment

Participating in This Clinical Trial

Inclusion Criteria

Women having medical abortion desiring progestin-based contraceptives (injectables or implants)

Gender Eligibility: Female

Minimum Age: N/A

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Gynuity Health Projects
  • Provider of Information About this Clinical Study
    • Sponsor

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.